Deucravacitinib in plaque psoriasis: Four-year safety and efficacy results from the Phase 3 POETYK PSO-1, PSO-2 and long-term extension trials.
Saved in:
| Title: | Deucravacitinib in plaque psoriasis: Four-year safety and efficacy results from the Phase 3 POETYK PSO-1, PSO-2 and long-term extension trials. |
|---|---|
| Authors: | Armstrong AW; University of California Los Angeles, Los Angeles, California, USA., Lebwohl M; Icahn School of Medicine at Mount Sinai, New York, New York, USA., Warren RB; Dermatology Centre, Northern Care Alliance NHS Foundation Trust, Manchester, UK.; NIHR Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK., Sofen H; University of California Los Angeles, Los Angeles, California, USA.; Dermatology Research Associates, Los Angeles, California, USA., Morita A; Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan., Paul C; Paul Sabatier University and CHU Larrey, Toulouse, France., Papp KA; Alliance Clinical Trials and Probity Medical Research, Waterloo, and the University of Toronto, Toronto, Ontario, Canada., Colombo MJ; Bristol Myers Squibb, Princeton, New Jersey, USA., Scotto J; Bristol Myers Squibb, Princeton, New Jersey, USA., Vaile J; Bristol Myers Squibb, Princeton, New Jersey, USA., Zhuo J; Bristol Myers Squibb, Princeton, New Jersey, USA., Vritzali E; Bristol Myers Squibb, Princeton, New Jersey, USA., Berger V; Bristol Myers Squibb, Princeton, New Jersey, USA., Schroeder G; Bristol Myers Squibb, Princeton, New Jersey, USA., Banerjee S; Bristol Myers Squibb, Princeton, New Jersey, USA., Thaçi D; Institute and Comprehensive Center for Inflammation Medicine, University of Lübeck, Lübeck, Germany., Strober B; Yale University School of Medicine, New Haven, and Central Connecticut Dermatology Research, Cromwell, Connecticut, USA. |
| Source: | Journal of the European Academy of Dermatology and Venereology : JEADV [J Eur Acad Dermatol Venereol] 2025 Jul; Vol. 39 (7), pp. 1336-1351. Date of Electronic Publication: 2025 Mar 06. |
| Publication Type: | Journal Article; Clinical Trial, Phase III; Randomized Controlled Trial; Multicenter Study |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 9216037 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-3083 (Electronic) Linking ISSN: 09269959 NLM ISO Abbreviation: J Eur Acad Dermatol Venereol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1468-3083 |
|---|---|
| DOI: | 10.1111/jdv.20553 |
